Ultragenyx Pharmaceutical, Inc. (RARE)

34.57 +0.44 (+1.29%) USD  |  NASDAQ  |  Dec 24, 12:59
34.57 0.00 (0.00%) After-Hours: 13:50
More

Ultragenyx Pharmaceutical SG&A Expense (TTM): 343.56M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for RARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. 2.717B
Amicus Therapeutics, Inc. 353.07M
Geron Corp. 160.96M
Vertex Pharmaceuticals, Inc. 1.644B
Fortress Biotech, Inc. 108.70M